EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.69 | 3-sulfoGalbeta(1,4)GlcNAcbeta(1,6)Galbeta(1,3)GalNAcalpha-O-benzyl | - |
Homo sapiens | |
2.4.1.69 | Galbeta(1,3)GalNAcalpha-O-allyl | - |
Homo sapiens | |
2.4.1.69 | Galbeta(1,4)GlcNAcbeta(1,6)3-sulfoGalbeta(1,3)-GalNAcalpha-O-benzyl | - |
Homo sapiens | |
2.4.1.69 | Galbeta(1,4)GlcNAcbeta(1,6)Galbeta(1,3)-GalNAcalpha-O-benzyl | - |
Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.4.1.69 | 0.31 | - |
Galbeta(1-3)GlcNAcbeta-O-allyl/acrylamide copolymer | - |
Homo sapiens | |
2.4.1.69 | 0.45 | - |
6-sulfoGalbeta(1-4)GlcNAcbeta-O-methyl | - |
Homo sapiens | |
2.4.1.69 | 0.5 | - |
fetuin triantennary asialoglycopeptide | - |
Homo sapiens | |
2.4.1.69 | 0.82 | - |
Galbeta-O-benzyl | - |
Homo sapiens | |
2.4.1.69 | 0.83 | - |
Galbeta(1-3)GlcNAcbeta-O-benzyl | - |
Homo sapiens | |
2.4.1.69 | 0.95 | - |
GDP-L-fucose | reaction with Galbeta(1-3)GalNAcalpha-O-allyl | Homo sapiens | |
2.4.1.69 | 1 | - |
bovine IgG diantennary glycopeptide | - |
Homo sapiens | |
2.4.1.69 | 1.33 | - |
GDP-L-fucose | reaction with Galbeta(1-3)GlcNAcbeta-O-allyl | Homo sapiens | |
2.4.1.69 | 1.54 | - |
GDP-L-fucose | reaction with 6-sulfoGalbeta(1-3)GlcNAcbeta-O-allyl | Homo sapiens | |
2.4.1.69 | 1.67 | - |
Galbeta(1-4)GlcNAcbeta-O-benzyl | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.69 | Homo sapiens | - |
recombinant and native enzyme | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.1.69 | ovarian cancer cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.69 | GDP-L-fucose + 6-sulfoGalbeta(1-4)GlcNAcbeta-O-methyl | - |
Homo sapiens | GDP + L-Fucalpha(1-2)6-sulfoGalbeta(1-4)GlcNAcbeta-O-methyl | - |
? | |
2.4.1.69 | GDP-L-fucose + beta-D-galactosyl-R | detailed characterization of specificity | Homo sapiens | GDP + alpha-L-fucosyl-1,2-beta-D-galactosyl-R | - |
? | |
2.4.1.69 | GDP-L-fucose + bovine IgG diantennary glycopeptide | - |
Homo sapiens | GDP + ? | - |
? | |
2.4.1.69 | GDP-L-fucose + fetuin triantennary asialoglycopeptide | - |
Homo sapiens | GDP + ? | - |
? | |
2.4.1.69 | GDP-L-fucose + Galbeta(1-3)GlcNAcbeta-O-allyl/acrylamide copolymer | - |
Homo sapiens | GDP + ? | - |
? | |
2.4.1.69 | GDP-L-fucose + Galbeta(1-3)GlcNAcbeta-O-benzyl | - |
Homo sapiens | GDP + L-Fucalpha(1-2)Galbeta(1-3)GlcNAcbeta-O-benzyl | - |
? | |
2.4.1.69 | GDP-L-fucose + Galbeta(1-4)GlcNAcbeta-O-benzyl | - |
Homo sapiens | GDP + L-Fucalpha(1-2)Galbeta(1-4)GlcNAcbeta-O-benzyl | - |
? | |
2.4.1.69 | GDP-L-fucose + Galbeta-O-benzyl | - |
Homo sapiens | GDP + L-Fucalpha(1-2)Galbeta-O-benzyl | - |
? |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.4.1.69 | 6 | 8 | enzyme from ovarian tumor | Homo sapiens |
2.4.1.69 | 7.2 | 7.6 | recombinant enzyme | Homo sapiens |
EC Number | pH Minimum | pH Maximum | Comment | Organism |
---|---|---|---|---|
2.4.1.69 | 6 | 7.6 | pH 6.0: 15% of maximal activity, pH 6.4: 59.2% of maximal activity, pH 6.8: 84.8% of maximal activity, pH 7.2-7.6: maximal activity, recombinant enzyme | Homo sapiens |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.4.1.69 | 5.6 | - |
Galbeta(1,3)GalNAcalpha-O-allyl | reaction with 6-sulfoGalbeta(1,3)GlcNAcbeta-O-allyl | Homo sapiens | |
2.4.1.69 | 5.9 | - |
Galbeta(1,4)GlcNAcbeta(1,6)Galbeta(1,3)-GalNAcalpha-O-benzyl | reaction with 6-sulfoGalbeta(1,4)GlcNAcbeta-O-methyl | Homo sapiens |